Oscar Brück
- Hematology top 5%
- Acute Myeloid Leukemia Research 6
- Immunology top 5%
- Immune Cell Function and Interaction 13
- Immune cells in cancer 8
- Immunotherapy and Immune Responses 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 6
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Satu MustjokiTeijo PellinenSirpa LeppäSuvi‐Katri LeivonenMarja‐Liisa Karjalainen‐LindsbergOlli KallioniemiKimmo PorkkaPanu E. Kovanen
- Cited by
- HematologyImmunologyGenetics
- Journals
- Journal of Clinical Investigation (1 paper)SHILAP Revista de lepidopterología (3 papers)Blood (4 papers)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Oscar Brück
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Hematology 271
- Immunology 441
- Genetics 174
- Oncology 427
- Pathology and Forensic Medicine 217
Countries citing papers authored by Oscar Brück
This map shows the geographic impact of Oscar Brück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar Brück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar Brück more than expected).
Fields of papers citing papers by Oscar Brück
This network shows the impact of papers produced by Oscar Brück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar Brück. The network helps show where Oscar Brück may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oscar Brück, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 60 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 38 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 36 | |
| 13 | 2021 | 35 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 47 | |
| 17 | 2020 | 35 | |
| 18 | 2020 | 16 | |
| 19 | 2019 | 59 | |
| 20 | 2017 | 33 |
About Oscar Brück
Oscar Brück is a scholar working on Hematology, Immunology and Oncology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Immune cells in cancer (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (271 citations), Immunology (441 citations) and Genetics (174 citations). Oscar Brück has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Satu Mustjoki, Teijo Pellinen, Sirpa Leppä, Suvi‐Katri Leivonen, Marja‐Liisa Karjalainen‐Lindsberg, Olli Kallioniemi, Kimmo Porkka, Panu E. Kovanen, Olli Dufva and Matias Autio. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.